President Abdel Fattah El-Sisi highlighted on Sunday 20/10/2024 Egypt's program with the International Monetary Fund (IMF), noting that the country may "review the situation" with global lender if the ...

President Abdel Fattah El-Sisi highlighted on Sunday 20/10/2024 Egypt’s program with the International Monetary Fund (IMF), ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

Liver cancer is the sixth-leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

The global hepatitis C virus (HCV) testing market is poised for significant growth, with its market size expected to ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

HHS breaks some notable new ground by proposing to account for receipt of HIV pre-exposure prophylaxis (PrEP) when ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...

[48] However, each regimen has advantages and disadvantages in certain patient populations, and the final choice of a treatment schedule ... and interface hepatitis on histological examination ...

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks ...

The findings are published in Clinical Infectious Diseases. Effective screening and treatment for hepatitis C virus in reproductive-aged women is a powerful tool for breaking the cycle of ...